Media Coverage header image

Media Coverage

Advanced Search
  • 06182019
    Long Island Business News Online

    A new law in New York City will prohibit most employers who operate there from conducting pre-employment drug testing for marijuana.[CR-LF][CR-LF]The law was passed last month and will go into effect May 10, 2020.[CR-LF][CR-LF]Certain positions, such as police officers, construction workers, commercial drivers, and workers caring for children or medical patients, among others, were excluded from the law.[CR-LF][CR-LF]About 2.8 percent of workers and job applicants tested positive for marijuana in 2018, according to Quest Diagnostics statistics.

  • 06172019
    PR Newswire - Online

    Individuals with prediabetes who participate in an employer-sponsored digital diabetes-prevention counseling program may reduce their risk of developing type 2 diabetes (T2D) for up to eight years, according to a new study from Quest Diagnostics (NYSE: DGX), the world's leading provider of diagnostic information services.[CR-LF][CR-LF]The new study, "Digital Behavioral Counseling in a Workforce Setting Reduces 8-Year Risk of Developing Type 2 Diabetes" (77-LB), is believed to be the first to suggest lower risk of diabetes may be sustained following participation in a time-limited digital Diabetes Prevention Program (DPP). DPPs, which typically consist of education modules on diet and exercise, are recognized by the Centers for Disease Control and Prevention (CDC) as an effective means of reducing risk for type 2 diabetes (T2D).

  • 06142019
    American Journal of Managed Care Online

    Medicare beneficiaries who had both diabetes and nonalcoholic fatty liver disease (NAFLD) or a more advanced version of inflammation and fat buildup, known as nonalcoholic steatohepatitis (NASH), had 2 times the mortality rate of the general population, according to data presented last week at the 79th Scientific Sessions of the American Diabetes Association (ADA).[CR-LF][CR-LF]The Global Liver Institute is raising awareness about NAFLD and NASH, and Wednesday marked the second International NASH Day. Both NAFLD and NASH are increasing worldwide with the increased prevalence of obesity, which now affects more than 650 billion people.[CR-LF]Diagnosis of NASH is difficult, as a definitive diagnosis requires a liver biopsy. However, Quest Diagnostics has developed the NAFLD Fibrosis Score Panel, a noninvasive tool to identify patients whose disease has progressed to liver fibrosis.

  • 06132019
    CBS News Online

    Two years after legalizing recreational marijuana, Nevada is telling job seekers: Light 'em up![CR-LF][CR-LF]Starting next year, employers won't be allowed to reject potential job seekers because they failed a test for marijuana use. According to a new law signed this month, an employer can't "fail or refuse to hire a prospective employee because the prospective employee submitted to a screening test and the results of the screening test indicate the presence of marijuana."[CR-LF][CR-LF]The substance remains illegal on the federal level, and is the most commonly detected illicit drug in employment drug testing, according to Quest Diagnostics. Traces of the drug can persist in someone's body for as long as 30 days after the last time they used it, some studies have found.

  • 06132019
    USA Today Online

    A positive test for marijuana in pre-employment drug screenings won't be a problem for most people in Nevada, beginning next year.[CR-LF][CR-LF]Nevada became the first state to approve such a drug test law last week, two years after recreational marijuana sales began in the Silver State. The law will not apply to EMTs, firefighters and those who drive vehicles, however. Employers can also reject job applicants for marijuana drug test results if usage can put others' safety at risk.Nationally, about 2.8% of urine-based workplace drug screenings tested positively for marijuana in 2018, according to Quest Diagnostics, a drug-testing service. Marijuana is also the most commonly detected illicit drug, according to the service.